Impaired recovery of noradrenaline levels in apolipoprotein E-deficient mice after N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine lesion

Neuroscience

Volumn 95, Issue 2, 1999, Pages 353-358

  Puolivali J ^a   Pradier, L ^b   Riekkinen Jr, P ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b Central Nervous System Department   (France)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cholinergic; DSP 4

Indexed keywords

APOLIPOPROTEIN E; NORADRENALIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; HORMONE DETERMINATION; HYPERLIPOPROTEINEMIA TYPE 3; LOCUS CERULEUS; MOUSE; NEUROTOXICITY; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL;

ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMALS; APOLIPOPROTEINS E; BENZYLAMINES; CEREBELLUM; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; FRONTAL LOBE; HIPPOCAMPUS; MICE; MICE, MUTANT STRAINS; NERVE DEGENERATION; NOREPINEPHRINE; SEROTONIN; SYMPATHOMIMETICS;

EID: 0345504167     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00448-0     Document Type: Article

References (24)

1. Anderson R., Barnes J.C., Bliss T.V., Cain D.P., Cambon K., Davies H.A., Errington M.L., Fellows L.A., Gray R.A., Hoh T., Stewart M., Large C.H., Higgins G.A. Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse. Neuroscience. 85:1998;93-110.
2. Anderson R., Higgins G.A. Absence of central cholinergic deficits in ApoE knockout mice. Psychopharmacology. 132:1997;135-144.
3. Arendt T., Schindler C., Bruckner M.K., Eschrich K., Bigl V., Zedlick D., Marcova L. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J. Neurosci. 17:1997;516-529.
4. Bertrand P., Poirier J., Oda T., Finch C.E., Pasinetti G.M. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Molec. Brain Res. 33:1995;174-178.
5. Chapman S., Michaelson D.M. Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice. J. Neurochem. 70:1998;708-714.
6. Chen Y., Lomnitski L., Michaelson D.M., Shohami E. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience. 80:1997;1255-1262.
7. Fisher A., Brandeis R., Chapman S., Pittel Z., Michaelson D.M. M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice. J. Neurochem. 70:1998;1991-1997.
8. Fonnum F.A. A rapid radiochemical method of the determination of choline acetyltransferase. J. Neurochem. 24:1975;402-409.
9. Fornai F., Bassi L., Torracca M.T., Alessandri M.G., Scalori V., Corsini G.U. Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents. Neurodegeneration. 5:1996;241-249.
10. Fritschy J.M., Grzanna R.J. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain. J. comp. Neurol. 321:1992;421-441.
11. Gordon I., Grauer E., Genis I., Sehayek E., Michaelson D.M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;1-4.
12. Jäkälä P., Sirviö J., Jolkkonen J., Riekkinen P. Jr., Acsady L., Riekkinen P. The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task. Behav. Brain Res. 51:1992;29-40.
13. Mann D.M.A. The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mech. Ageing Development. 23:1983;73-94.
14. Marcyniuk B., Mann D.M.A., Yates P.O. The topography of cell loss from locus coeruleus in Alzheimer's disease. J. neurol. Sci. 76:1986;335-345.
15. Masliah E., Mallory M., Alford M., Ge N. and Mucke L. (1995) Abnormal synaptic regeneration in hAPP695 transgenic and APOE knockout mice. In Research Advances in Alzheimer's Disease and Related Disorders (eds Iqbal K., Mortimer J. A., Winblad B. and Wisniewski H. M.), pp. 405-414. John Wiley, New York.
16. Masliah E., Mallory M., Alford M., Veinbergs I. and Roses A. D. (1995) Apolipoprotein E role in maintaining the integrity of the aging central nervous system. In Apolipoprotein E and Alzheimer's Disease (ed. Roses A. D.), pp. 59-73. Springler, New York.
17. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., Roses A.D. Neurodegeneration in the CNS of apoE-deficient mice. Expl Neurol. 136:1995;107-122.
18. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. natn. Acad. Sci. U.S.A. 89:1992;4471-4475.
19. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
20. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17:1994;525-530.
21. Poirier J., Baccichet A., Dea D., Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience. 55:1993;81-90.
22. Popko B., Goodrum J.F., Bouldin T.W., Zhang S.H., Maeda N. Nerve regeneration occurs in the absence of apolipoprotein E in mice. J. Neurochem. 60:1993;1155-1158.
23. Soininen H., Kosunen O., Helisalmi S., Mannermaa A., Paljarvi L., Talasniemi S., Ryynänen M., Riekkinen P. Sr. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. Neurosci. Lett. 187:1995;79-82.
24. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:1992;468-471.